CLINICAL_TRIALS
research
· 2026-03-18
Clinical Trial Update: Trifecta-Kidney cfDNA-MMDx Study
Summary
A University of Alberta-led clinical trial is currently recruiting to evaluate the trifecta-kidney cfDNA-MMDx diagnostic approach for kidney transplant rejectio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Kidney Transplant Rejection | Status: RECRUITING